Weekly Epidemiological Report

January 2024 Week 2

Editoral

Weekly updates on epidemics in Nigeria; as at 14th January, 2024

Posted: 09-10-2024 08:25:47 AM

Summary of Incidents

1. Information for this disease was retrieved from the Technical Working Group and Situation Reports

2. Case Fatality Rate (CFR) for this disease is reported for confirmed cases only.

3. CFR for this disease is reported for total cases i.e. suspected + confirmed.

4. Information for sentinel influenza was retrieved from the laboratory.


Lassa Fever

Key points

1. There were 296 suspected cases of Lassa Fever reported from 30 LGAs in 15 states. There were 81 laboratory confirmed cases and 16 deaths were recorded.

Actions

To date:

1. National Lassa fever multi-partner, multi-sectoral Technical Working Group (TWG) continues to coordinate the response activities at all levels.

2. Participated in ERPHC workshop for the review of IDSR/IPC foundational course

3. Send alert letters to all states, the FCT, and the NGF


Cerebrospinal Meningitis (CSM)

Key points

1. There were 76 suspected cases of Cerebrospinal meningitis (CSM) reported from 21 LGAs in nine states. There was one laboratory confirmed case and nine deaths were reported.

Actions

To date:

1. National CSM TWG meets weekly to review reports from states and plan appropriately.


Yellow Fever

Key points

1. There were 71 suspected cases of Yellow Fever (YF) reported from 56 LGAs in 24 states. There was no laboratory confirmed case and no death was recorded.

Actions

To date:

1. National YF multi-partner Technical Working Group (TWG) continues to coordinate activities across states.

2. Daily monitoring and analysis of surveillance data across the country to guide response activities.

3. Coordination of yellow fever sample management and transportation from all states to the regional reference laboratories

4. Operationalization of Yellow fever Reference Laboratory at University of Maiduguri Teaching Hospital (UMTH) Maiduguri, Borno State


Cholera

Key points

1. There were 86 suspected cases of Cholera reported from 17 LGAs in eight states. There was no laboratory confirmed case and no death was recorded.

Actions

To date

1. National Cholera Multi-Sectoral Technical Working Group (TWG) is monitoring all states and supporting affected states.

2. Ongoing surveillance in all states through the routine Integrated Disease Surveillance and Response (IDSR) and Event Based Surveillance (EBS).

3. Cholera surveillance evaluation across states.


Measles

Key points

1. There were 637 suspected cases of Measles reported from 140 LGAs in 28 states. There were 86 laboratory confirmed cases and five deaths were recorded.

Actions

To date

1. National Measles TWG is closely monitoring measles surveillance data and providing feedback to relevant agencies and development partners.

2. Ongoing weekly surveillance and laboratory data harmonisation.


Mpox

Key points

1. There were six suspected cases of Mpox reported from six LGAs in six states. There was no laboratory confirmed case and no death was recorded.

Actions

To date

1. National Mpox Technical Working Group (TWG) is monitoring activities in all states.


Acute Flaccid Paralysis (AFP)

Key points

1. There were 137 suspected cases of AFP reported from 112 LGAs in 31 states and FCT. There was no laboratory confirmed case and no death was recorded.


National Influenza Sentinel Surveillance


Coronavirus Disease (COVID-19)

Key points

1. There were eleven suspected cases of Covid-19 reported from seven LGAs in four states and FCT. There were eleven confirmed cases and no death recorded

Actions

To date:

2. Multi-sectoral Public Health Emergency Operation Centres (PHEOC) activated at the National and affected States.


Diphtheria

Key points

1. There were 584 suspected cases of Diphtheria reported from 70 LGAs in ten state and FCT. There were 283 confirmed cases, and six deaths were recorded.

Actions

To date

1. National Diphtheria Technical Working Group (TWG) is monitoring activities in all states.

2. Harmonisation of surveillance and laboratory data from across states and laboratories.

3. Provision of off-site surveillance support to affected States.


Event Based Surveillance (EBS)

Highlight of the week

  • Summary of Incidents
  • Lassa Fever
  • Cerebrospinal Meningitis (CSM)
  • Yellow Fever
  • Cholera
  • Measles
  • Mpox
  • Acute Flaccid Paralysis (AFP)
  • National Influenza Sentinel Surveillance
  • Coronavirus Disease (COVID-19)
  • Diphtheria
  • Event Based Surveillance (EBS)

Connect Centre